| __timestamp | ADMA Biologics, Inc. | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4823869 | 2917513 |
| Thursday, January 1, 2015 | 6745968 | 7878291 |
| Friday, January 1, 2016 | 8494742 | 8366794 |
| Sunday, January 1, 2017 | 18092835 | 6610381 |
| Monday, January 1, 2018 | 22502922 | 6556000 |
| Tuesday, January 1, 2019 | 25910757 | 6930000 |
| Wednesday, January 1, 2020 | 35050817 | 8758000 |
| Friday, January 1, 2021 | 42896889 | 10806000 |
| Saturday, January 1, 2022 | 52458024 | 9844000 |
| Sunday, January 1, 2023 | 59020000 | 13481000 |
Igniting the spark of knowledge
In the competitive landscape of biotechnology, effective cost management is crucial. Over the past decade, ADMA Biologics, Inc. and Soleno Therapeutics, Inc. have demonstrated contrasting strategies in managing their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, ADMA Biologics saw a staggering 1,125% increase in SG&A expenses, peaking at nearly $59 million in 2023. This reflects their aggressive expansion and investment in operational capabilities. In contrast, Soleno Therapeutics maintained a more conservative approach, with a 362% increase over the same period, reaching approximately $13 million in 2023. This strategic restraint may indicate a focus on lean operations and targeted growth. Understanding these trends provides valuable insights into how biotech companies balance growth ambitions with financial prudence.
Intra-Cellular Therapies, Inc. vs ADMA Biologics, Inc.: SG&A Expense Trends
Summit Therapeutics Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Exelixis, Inc. and Soleno Therapeutics, Inc.
Halozyme Therapeutics, Inc. or ADMA Biologics, Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Cytokinetics, Incorporated and Soleno Therapeutics, Inc.
Selling, General, and Administrative Costs: Axsome Therapeutics, Inc. vs ADMA Biologics, Inc.
ADMA Biologics, Inc. or ACADIA Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of ADMA Biologics, Inc. and Mesoblast Limited
Selling, General, and Administrative Costs: Amneal Pharmaceuticals, Inc. vs Soleno Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Viking Therapeutics, Inc. and Soleno Therapeutics, Inc.
Merus N.V. vs Soleno Therapeutics, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for HUTCHMED (China) Limited and Soleno Therapeutics, Inc.